Mochel
Fanny Mochel, Dallas, TX US
Patent application number | Description | Published |
---|---|---|
20110306663 | TRIHEPTANOIN DIET FOR ADULT POLYGLUCOSAN BODY DISEASE (APBD) TREATMENT - Compositions and methods for the treatment and management of adult polyglucosan body disease (APBD) are disclosed herein. The APBD patients studied in the present invention experienced stabilization of disease progression and limited functional improvement with dietary triheptanoin (C7TG). The amount of C7TG administered to the patient daily for 6-8 months was 1-2 g/kg/24 hrs. The present invention demonstrates, for the first time, the arrest of clinical deterioration with limited functional recovery in APBD with triheptanoin diet therapy. | 12-15-2011 |
Fanny Mochel, Saint Maur Des Fosses FR
Patent application number | Description | Published |
---|---|---|
20100063147 | Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases - The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine diseases, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof. | 03-11-2010 |
20120165405 | Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases - The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine diseases, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof. | 06-28-2012 |
20140364498 | Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases - The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine diseases, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof. | 12-11-2014 |
Fanny Mochel, Paris FR
Patent application number | Description | Published |
---|---|---|
20140221482 | TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORT 1 DEFICIENCY - Provided are methods for treating GLUT1 and related brain energy deficiencies comprising administering odd-carbon fatty acid sources, e.g., C5 or C7 fatty acid sources, and related compositions. | 08-07-2014 |
Howard Grayston Mochel, Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20140068984 | Front loading frame on rail display system - A front loading frame on rail display system includes a support rail assembly secured to a wall and a display frame assembly secured to the support rail. The rail assembly includes a wall rail secured to the wall with a top rail secured thereto and receiving an apron crown molding. The frame assembly includes a frame unit formed by top and side frame members and closed by a back panel. The frame members have notched glass clips which are aligned in a plane. Display materials are front loaded into the frame unit, and a glass pane is slid into the clips. Fasteners extending from the side frame members are received in rotary lock members positioned in the top rail. The lock members are rotated to lock positions to engage heads of the fasteners to removably secure the frame assembly to the rail assembly. | 03-13-2014 |
Kari Mochel, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100205567 | ADAPTIVE UI REGIONS FOR ENTERPRISE APPLICATIONS - An adaptive region system can include an adaptive region module and a display module. The adaptive region module can include a mini region button panel module capable of generating a mini region button panel having multiple mini region buttons, a view panel module capable of generating a view panel having multiple view buttons, and a region panel module capable of generating a region panel having multiple mini regions. The display module can visually display the mini region button panel, the view panel, and the region panel. | 08-12-2010 |
Ken Mochel, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090069746 | Data Storage for an Infusion Pump System - A pump system can include a pump device and a controller device removably attachable to the pump device. The controller device can be reusable, and one or more pump devices can be disconnected and reconnected to the controller device. As such, some pump usage data can be conveniently stored in the pump device itself. In such circumstances, the controller device can receive data related to the pump's history or other usage when the pump device is attached to the controller. | 03-12-2009 |
20090069749 | Power Management Techniques for an Infusion Pump System - Some embodiments of an infusion pump system can employ a number of power management techniques to avoid using substantially excessive power during operation of the pump drive system. Thus, the infusion pump system can draw upon the energy supply in an efficient manner that extends the useful life on the power supply. Furthermore, the infusion pump system can be configured estimate an amount of power remaining to operate the pump system without the requirement of directly detecting the remaining charge on power supply device (e.g., without detecting the remaining charge on a battery). As such, the infusion pump system can readily inform a user of a particular estimated amount of time remaining for medicine dispensing operations. | 03-12-2009 |
20110202004 | Data Storage for an Infusion Pump System - A pump system can include a pump device and a controller device removably attachable to the pump device. The controller device can be reusable, and one or more pump devices can be disconnected and reconnected to the controller device. As such, some pump usage data can be conveniently stored in the pump device itself. In such circumstances, the controller device can receive data related to the pump's history or other usage when the pump device is attached to the controller. | 08-18-2011 |
20120220936 | Data Storage for an Infusion Pump System - A pump system can include a pump device and a controller device removably attachable to the pump device. The controller device can be reusable, and one or more pump devices can be disconnected and reconnected to the controller device. As such, some pump usage data can be conveniently stored in the pump device itself. In such circumstances, the controller device can receive data related to the pump's history or other usage when the pump device is attached to the controller. | 08-30-2012 |
20130012917 | Power Management Techniques for an Infusion Pump System - Some embodiments of an infusion pump system can employ a number of power management techniques to avoid using substantially excessive power during operation of the pump drive system. Thus, the infusion pump system can draw upon the energy supply in an efficient manner that extends the useful life on the power supply. Furthermore, the infusion pump system can be configured estimate an amount of power remaining to operate the pump system without the requirement of directly detecting the remaining charge on power supply device (e.g., without detecting the remaining charge on a battery). As such, the infusion pump system can readily inform a user of a particular estimated amount of time remaining for medicine dispensing operations. | 01-10-2013 |
20140213977 | Data Storage for an Infusion Pump System - A pump system can include a pump device and a controller device removably attachable to the pump device. The controller device can be reusable, and one or more pump devices can be disconnected and reconnected to the controller device. As such, some pump usage data can be conveniently stored in the pump device itself. In such circumstances, the controller device can receive data related to the pump's history or other usage when the pump device is attached to the controller. | 07-31-2014 |
Tobias Mochel, Leicestershire GB
Patent application number | Description | Published |
---|---|---|
20080262037 | Piperidine Derivatives for the Treatment of Chemokine Mediated Disease - The present invention provides a compound of a formula (I) wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state. | 10-23-2008 |
20090012125 | Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them - The present invention provides a compound of a formula (I): [Chemical formula should be inserted here. Please see paper copy] wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state. | 01-08-2009 |
20090118513 | Chemical Compounds - The present invention provides a compound of a formula (I): | 05-07-2009 |
Tobias Mochel, Loughborough GB
Patent application number | Description | Published |
---|---|---|
20080300244 | NOVEL COMPOUNDS - The present invention provides compounds of formula | 12-04-2008 |
20090209524 | Novel Compounds - The present invention provides compounds of formula (1) | 08-20-2009 |
20130045955 | NOVEL COMPOUNDS - The present invention provides compounds of formula (I) | 02-21-2013 |